Fig. 3From: Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximabEffects of TPE combined therapy in prospective cohort a. Serum suPAR levels were significantly reduced after treatment. * p < 0.05. b Proteinuria was significantly decreased after treatment. ** p < 0.01. c Serum creatinine was marginally but not significantly improved after combined therapy. d The patient serum induced podocyte AP5 activity was significantly reduced after treatment. * p < 0.05Back to article page